# Novo Nordisk a S: Form 20-F for the period ended Dec 31, 2021

- Company: [Novo Nordisk a S](/companies/nvo.md) (CIK 353278)
- Form: 20-F
- Filed: 2022-02-02
- Accepted by EDGAR: Feb 2, 2022, 09:06 ET
- Period: 2021-12-31
- Accession: 0001628280-22-001639
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/nvo-20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | DKK 140.80bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | DKK 23.66bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | DKK 117.14bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | DKK 58.64bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | DKK 11.32bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | DKK 47.76bn | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | DKK 20.74 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | DKK 20.79 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | DKK 55.00bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | DKK 6.33bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2021-12-31 | DKK 10.72bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2021-12-31 | DKK 85.59bn | ifrs-full:CurrentAssets |
| Total assets | at 2021-12-31 | DKK 194.51bn | ifrs-full:Assets |
| Current liabilities | at 2021-12-31 | DKK 99.52bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2021-12-31 | DKK 123.76bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2021-12-31 | DKK 70.75bn | ifrs-full:Equity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/nvo-20211231.htm

Filed Feb 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-001639. Last ingested by Listed: Nov 9, 2026, 17:51 ET. No prices; not investment advice.
